Clinical Trials Directory

Trials / Completed

CompletedNCT01239381

Individualized Stereotactic Body Radiotherapy of Liver Metastases

Phase II Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
92 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Stereotactic body radiation therapy (SBRT) is a technique that is used to deliver radiation, to sites in the body. All participants in this study will be treated with SBRT using proton beam radiation. Proton beam radiation uses tiny particles to deliver radiation to tumors. The purpose of this research study is to determine if SBRT with protons will prevent tumor growth and reduce the treatment side effects for liver metastases.

Detailed description

* Participants receiving SBRT with protons, will receive radiation treatment as an outpatient at the Francis H. Burr Proton Therapy Center at Massachusetts General Hospital. * Not everyone who participates in this study will be receiving the same dose of radiation. The dose received will be determined by the size and location of the tumor(s). * Participants will receive 2-3 SBRT treatments per week for two weeks. * During radiation therapy visits the following tests/procedures will be performed: vital signs, physical examination, routine blood tests, research blood tests, and radiation planning. * Follow-up assessments will be performed once at 9 weeks after study treatment, then at 6 months, 12 months, 18 months and 24 months after treatment.

Conditions

Interventions

TypeNameDescription
RADIATIONStereotactic body radiotherapy-protonDose will be determined by the size and location of the tumor(s); 2-3 treatments per week for two weeks

Timeline

Start date
2010-10-05
Primary completion
2016-01-01
Completion
2017-09-01
First posted
2010-11-11
Last updated
2025-09-30
Results posted
2017-07-13

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01239381. Inclusion in this directory is not an endorsement.

Individualized Stereotactic Body Radiotherapy of Liver Metastases (NCT01239381) · Clinical Trials Directory